Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Bibliographic Details
Title:	Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein
Authors:	Wang, Yu, Ding, Xiwei, Wang, Shaoqing, Moser, Catherine D., Shaleh, Hassan M., Mohamed, Essa A., Chaiteerakij, Roongruedee, Allotey, Loretta K., Chen, Gang, Miyabe, Katsuyuki, McNulty, Melissa S., Ndzengue, Albert, Barr Fritcher, Emily G., Knudson, Ryan A., Greipp, Patricia T., Clark, Karl J., Torbenson, Michael S., Kipp, Benjamin R., Zhou, Jie, Barrett, Michael T., Gustafson, Michael P., Alberts, Steven R., Borad, Mitesh J., Roberts, Lewis R. ^*
Source:	In Cancer Letters 28 September 2016 380(1):163-173
Database:	ScienceDirect